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The preparation of autologous cells for therapy requires the aseptic expansion and differentiation of stem cells 
at relatively small scale. For the maximum number of patients to benefit methods for the parallel processing of 
large numbers of patient biopsies are required. This presentation outlines an automated, single-use approach to 
cell expansion and modeling tools that can give clinicians an early indication of when sufficient cells will be 
available for implanting back into the patient. 
 
The approach is illustrated for the expansion of human Mesenchymal Stromal Cells (hMSC). These have the 
potential to differentiate into lineages of mesoderm origin, such as osteogenic, chondrogenic, and adipogenic 
lineages, presenting a promising potential for regenerative medicine applications. One of the major challenges 
associated with delivering hMSC to the clinic is the ability to propagate the cells in sufficient numbers for 
regenerative medicine therapies. Some of the reasons for this are, the low number of cells isolated from primary 
tissues, low growth rates in vitro, and the low population doubling limit of these cells before undirected 
differentiation and senesce occurs. The experimental studies describe the optimization of hMSC culture 
conditions in single-use, microwell formats and the use of a previously developed laboratory automation 
platform [1] to help reduce the time required between biopsy and treatment. Results from related studies on 
control of microenvironmental conditions to optimize differentiation will also be shown for comparison. [2] 
 
In the case of hMSCs, cell growth kinetics were studied for cells isolated from frozen bone marrow samples from 
different donors and over sequential passages. Growth rates were found to be an intrinsic characteristic of the 
donor, decreasing consistently with increasing passage number, or population doublings. The overall duration of 
the cell expansion process in the automated platform was optimized by studying the effect of controlled 
parameters on cell growth kinetics and differentiation. The effect of inoculation cell density, feeding strategy, pH, 
and temperature on cell growth was determined, and optimum parameters were chosen to reduce the overall 
processing time needed to achieve the required number of cells for autologuous cell therapy. The quality of the 
final cell population was shown to be maintained throughout the cell expansion process based on cell surface 
marker expression. 
 
For clinical applications the inability to predict the growth rate of isolated cells from a patient at each stage of the 
cell expansion provides a major obstacle towards the design of a time based automated bioprocess. In order to 
define processing times for the overall cell expansion of hMSC in an undifferentiated state, a simple 
mathematical model was developed to describe the kinetics of growth for each passage based on the 
parameters obtained from passage one after hMSC isolation from an individual patient. This model can forward 
predict processing times at each passage for each donor, taking into consideration the decrease in growth rates 
associated with the increase in cell doublings. The validity of the model was tested with hMSC isolated from five 
different donors, and proven to be accurate in all cases. 
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